Cannabis

The three main species typically recognized within the Cannabis sativa L. family include Cannabis sativa, Cannabis indica and Cannabis ruderalis. The most well-known compounds found within the cannabis plant are THC, cannabidiol (CBD) and cannabinol (CBN).

CBD Oil: Health Benefits and Risks

There is a growing interest in CBD as a potential drug in the treatment of a wide spectrum of neurologic and neuropsychiatric disorders. However, caution must be taken.

Cannabis and Psychosis

Hemp Seed Oil Health Benefits

Does Smoking Cannabis Indoors Affect Children's Health?

Health Effects of Eating Cannabis (Marijuana)

Can Cannabis Use Alter Sperm DNA?

The Potential Advantages of Patient-Directed Cannabis Therapy

Does CBD Oil Work for Arthritis Pain?

Cannabis Use and Acute Myocardial Infarctions in Young People

Using a Portable Raman Spectrometer for Detection of THC

Synthesizing Cannabis from Yeast

Latest Cannabis News and Research

Cannabis use linked to poorer sleep and memory problems

The growing legal use of recreational and medical cannabis has generated an increased concern for potential side effects from long-term use, particularly regarding problems with memory and sleep.

5 Sep 2024

Study reveals slight increase in ADHD risk from prenatal cannabis exposure

A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the risk of ADHD and a heightened vulnerability to cannabis use in offspring.

3 Sep 2024

Cannabis and hallucinogen use stayed at historically high among adults in 2023

The percentages of adults using cannabis and hallucinogens over the past year stayed at historically high levels in 2023, according to the latest findings from the University of Michigan’s Monitoring the Future survey.

29 Aug 2024

Psychedelics: A new hope for substance abuse treatment

Study explores the history and current state of psychedelic research for treating substance abuse disorders, highlighting challenges like restrictive policies, lack of funding, and the need for recognition of traditional and modern therapeutic practices.

28 Aug 2024

Recreational drug users three times more likely to experience repeat cardiovascular events

New research presented at this year's ESC Congress 2024 in London, UK (30 Aug – 2 Sept) shows that, among patients admitted to the intensive cardiac care unit (ICCU), those with a recent history of recreational drug use are three times more likely than those with no history to experience a repeat serious cardiovascular event within one year.

28 Aug 2024

Long-term low-dose cannabis reverses brain aging in mice

A low-dose long-term administration of cannabis can not only reverse aging processes in the brain, but also has an anti-aging effect.

22 Aug 2024

Leading health issues affecting older adults before the 2024 elections

Researchers surveyed adults aged ≥50 years to identify the most salient health concerns before the 2024 elections in the United States.

20 Aug 2024

Vaping linked to higher risk of cigarette smoking and drug use in teens, young adults

U.S. teens and young adults who vape are much more likely to start smoking cigarettes or to begin using cannabis or other drugs, a new University of Michigan study found.

16 Aug 2024

Does cannabis use disorder increase the risk of head and neck cancer?

Researchers determine whether cannabis use disorder increases the risk of head and neck cancer.

12 Aug 2024

Cannabis dependence associated with increased occurrence of head and neck cancer

A study from the USC Head and Neck Center, part of Keck Medicine of USC and the USC Caruso Department of Otolaryngology – Head and Neck Surgery, suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck cancer.

8 Aug 2024

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

In this interview conducted at Pittcon 2024, we spoke to Professor John Yates about capturing cardiomyocyte cell-to-cell heterogeneity via shotgun top-down proteomics.

From Pittcon 6 Aug 2024

Cannabigerol shows promise in reducing anxiety and stress, study finds

Whether the phytocannabinoid cannabigerol impacted mood, stress, and anxiety and caused any related adverse effects of cognitive or motor impairment.

5 Aug 2024

How states pioneered the medical marijuana movement in America

From the war on drugs to the current wave of legalization efforts, public opinion in the United States has shifted on few issues like it has with marijuana.

1 Aug 2024

Study finds cannabigerol effectively reduces anxiety, boosts memory recall

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis.

31 Jul 2024

From Waste to Taste: The Transformative Power of Fermented Foods

In this interview conducted at Pittcon 2024 in San Diego, Maria Marco discusses her research on the health benefits, safety, and waste reduction potential of fermented foods, and the microbial processes involved in their production.

From Pittcon 31 Jul 2024

Semaglutide may reduce smoking risks for diabetes patients

Semaglutide shows promise in reducing tobacco use disorder-related health encounters in patients with type 2 diabetes, but further clinical trials are needed to confirm its efficacy.

29 Jul 2024

E-Cigarettes and Ethanol: A Forensic Perspective on Vaping

In this interview conducted at Pittcon 2024 in San Diego, we spoke to Professor Michelle Peace about the challenges and implications of detecting ethanol in e-cigarettes for drug testing and forensic toxicology.

From Pittcon 23 Jul 2024

Increased cannabis use in diabetics raises concerns about health risks

Researchers at University of California San Diego School of Medicine have found a significant increase in cannabis use among adults with diabetes in the United States, raising concerns about the potential impact on their health outcomes. The new study, which analyzed nationally representative data from the 2021-2022 National Survey on Drug Use and Health (NSDUH), estimated that 9.0 percent of adults with diabetes used cannabis in the past month, with a 33.7 percent increase in prevalence-;from 7.7 percent to 10.3 percent-;between 2021 and 2022.

23 Jul 2024

Cannabigerol shows promise in reducing anxiety and enhancing memory without side effects

Researchers at Washington State University found that cannabigerol (CBG) reduces anxiety and improves verbal memory without causing intoxication or impairments in healthy adults.

15 Jul 2024

How may cannabis affect neurodevelopment when exposed in the womb?

Researchers investigated whether prenatal cannabis exposure is related to variations in brain development, which may partially mitigate the relationship between PCE and increased psychopathology throughout early adolescence.

9 Jul 2024